Search Results - "Akgül, S.U"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Relevance of Flow Cytometric Auto-Crossmatch to the Post-transplant Course of Kidney Transplant Recipients by Demir, E, Yeğit, O, Erol, A, Akgül, S.U, Çalışkan, B, Bayraktar, A, Çalışkan, Y, Türkmen, A, Savran, F.O, Sever, M.S

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Introduction The crossmatch test is essential prior to kidney transplantation (tx) to confirm compatibility between the donor and the recipient…”
    Get full text
    Journal Article
  2. 2

    Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates by Akgul, S.U, Ciftci, H.S, Temurhan, S, Caliskan, Y, Bayraktar, A, Tefik, T, Kaya, I.A, Canitez, I.O, Demir, E, Yazici, H, Bakkaloglu, H, Aydin, A.E, Turkmen, A, Nane, I, Aydin, F, Oguz, F.S

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Background Human leukocyte antigen (HLA) allo-immunization is caused by various events such as blood transfusions, pregnancies, or organ…”
    Get full text
    Journal Article
  3. 3

    Tac-MMF Versus CsA-MMF/CsA-AZA–Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation by Sahutoglu, T, Akgul, S.U, Caliskan, Y, Yazici, H, Demir, E, Kara, E, Temurhan, S, Savran, F.O, Turkmen, A

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Background Immunosuppressive regimens with tacrolimus or cyclosporine A (CsA) were compared for graft-related outcomes in conjunction with…”
    Get full text
    Journal Article
  4. 4

    Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software by Karadeniz, S.T, Akgul, S.U, Ogret, Y, Ciftci, H.S, Bayraktar, A, Bakkaloglu, H, Caliskan, Y, Yelekci, K, Turkmen, A, Aydin, A.E, Oguz, F.S, Carin, M, Aydin, F

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Introduction High rates of panel-reactive antibody (PRA) may decrease the chance of kidney transplantation and may result in long waiting periods…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy by Temurhan, S, Akgul, S.U, Caliskan, Y, Artan, A.S, Kekik, C, Yazici, H, Demir, E, Caliskan, B, Turkmen, A, Oguz, F.S, Sever, M.S

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Background The serum levels of galactose-deficient immunoglobulin (Ig)A1 (Gd-IgA1) represent the most promising candidate biomarker for IgA…”
    Get full text
    Journal Article
  7. 7

    The Effect of Glutathion S-Transferase Polymoprhisms and Anti-GSST1 Antibodies on Allograft Functions in Recipients of Renal Transplant by Akgul, S.U, Oguz, F.S, Çalişkan, Y, Kekik, C, Gürkan, H, Türkmen, A, Nane, I, Aydin, F

    Published in Transplantation proceedings (01-07-2012)
    “…Abstract The balance between oxidative stress and anti-oxidant defense systems after renal transplantation may explain the development and progression of…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients by Khishigsuren, B., Demir, E., Akgul, S.U., Temurhan, S., Ucar, A.R., Dirim, A.B., Catikkas, N.M., Bayraktar, A., Caliskan, Y., Yazici, H., Oguz, F.S., Turkmen, A., Sever, M.S.

    Published in Transplantation proceedings (01-05-2019)
    “…Seasonal influenza is an important cause of morbidity and mortality in the post-transplant period; therefore, the influenza vaccination has been recommended…”
    Get full text
    Journal Article
  9. 9

    Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients by Aliyeva, N., Demir, E., Akgul, S.U., Temurhan, S., Ucar, A.R., Dirim, A.B., Bayraktar, A., Catikkas, N.M., Erol, A., Caliskan, Y., Yazici, H., Yelken, B., Savran, F.O., Turkmen, A.

    Published in Transplantation proceedings (01-05-2019)
    “…Cardiovascular disease is the leading cause of mortality in kidney transplant recipients. Rituximab is widely used in kidney transplantation for a variety of…”
    Get full text
    Journal Article